Sanofi Goodwill and Intangible Assets 2012-2026 | SNY

Sanofi goodwill and intangible assets for the quarter ending March 31, 2026 were $80.858B, a 20.28% increase year-over-year.

  • Sanofi goodwill and intangible assets for 2024 were $71.433B, a 10.47% decline from 2023.
  • Sanofi goodwill and intangible assets for 2023 were $79.79B, a 5.87% increase from 2022.
  • Sanofi goodwill and intangible assets for 2022 were $75.366B, a 8.29% decline from 2021.

Sanofi Goodwill and Intangible Assets 2012-2026 | SNY

  • Sanofi goodwill and intangible assets for 2024 were $71.433B, a 10.47% decline from 2023.
  • Sanofi goodwill and intangible assets for 2023 were $79.79B, a 5.87% increase from 2022.
  • Sanofi goodwill and intangible assets for 2022 were $75.366B, a 8.29% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B